8 Steven Cohen Celldex Therapeutics Trades
Steven Cohen's position in Celldex Therapeutics is currently worth $99.9 Million. That's 0.30% of their equity portfolio (93rd largest holding). The investor owns 4.64% of the outstanding Celldex Therapeutics stock. The first Celldex Therapeutics trade was made in Q1 2021. Since then Steven Cohen bought shares five more times and sold shares on two occasions. The stake costed the investor $87.3 Million, netting the investor a gain of 14% so far.
Avg closing price
Price range
Increased shares by 105.3% (+1.41 Million shares)
Q4 2023
Avg closing price
$29.41
Price range
$22.61
-
$40.65
Increased shares by 13.3% (+158 Thousand shares)
Q3 2023
Avg closing price
$31.35
Price range
$25.45
-
$37.46
Increased shares by 416.2% (+955 Thousand shares)
Q2 2023
Avg closing price
$33.70
Price range
$30.29
-
$38.28
Sold 54.6% shares (-276 Thousand shares)
Q1 2023
Avg closing price
$43.15
Price range
$34.78
-
$47.43
Increased shares by 274.7% (+371 Thousand shares)
Q4 2022
Avg closing price
$35.70
Price range
$27.78
-
$45.38
New holding (+135 Thousand shares)
Q3 2022
Avg closing price
$30.66
Price range
$22.70
-
$37.57
Sold -46.1 Thousand shares
Q2 2021
Avg closing price
$27.45
Price range
$20.71
-
$35.37
New holding (+46.1 Thousand shares)
Q1 2021
Avg closing price
$22.96
Price range
$16.19
-
$29.91
